Sponsored by:

Nuclear Medicine: Page 50

Shine forms therapeutics division
By AuntMinnie.com staff writers
Medical isotope firm Shine Medical Technologies has launched Shine Therapeutics, a new division that will target the market for therapeutic isotopes.
October 13, 2019
2016 09 13 17 07 43 134 Atomic Technology 400
Biodex joins forces with Canadian shielding firm
By AuntMinnie.com staff writers
Medical imaging accessory supplier Biodex Medical Systems has formed a strategic partnership with isotope shielding technology provider South West Exposures of Canada for the theranostics and nuclear medicine markets.
October 13, 2019
2018 04 24 20 24 4264 Isotope 400
IBA and CAMH partner to build nuclear medicine program
By AuntMinnie.com staff writers
Proton therapy developer Ion Beam Applications (IBA) and Azrieli Centre for Neuro-Radiochemistry at CAMH (Centre for Addiction and Mental Health) in Toronto have entered into a long-term agreement to promote nuclear medicine via R&D and a clinical program.
October 10, 2019
2019 09 21 00 44 1021 Iba Astro 2019
Sofie signs deal with ABX for cGMP compliance
By AuntMinnie.com staff writers
Molecular imaging developer Sofie Biosciences has signed an agreement with ABX Advanced Biochemical Compounds of Radeberg, Germany, for ABX to provide Sofie with current good manufacturing practice (cGMP) precursor and reference standards for Sophie's fibroblast activation protein inhibitor compounds.
October 9, 2019
GE, Theragnostics partner on PSMA agent
By AuntMinnie.com staff writers
GE Healthcare and Theragnostics have signed a global partnership to develop a new prostate-specific membrane antigen (PSMA) PET/CT imaging agent.
October 8, 2019
2016 10 04 11 38 34 158 Prostate 400
ImaginAb touts research on T-cell PET imaging agent
By AuntMinnie.com staff writers
Imaging agent developer ImaginAb said data from the first-in-human imaging study of its CD8 T-cell PET agent for use in detecting solid malignancies were published online October 4 in the Journal of Nuclear Medicine.
October 7, 2019
2018 11 06 23 34 9504 Pet Scan Patient 400
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
October 7, 2019
Shine secures $50M in financing
By AuntMinnie.com staff writers
Medical isotope firm Shine Medical Technologies has secured $50 million in financing with funds managed by Oaktree Capital Management of Los Angeles.
October 7, 2019
2016 09 13 17 07 43 134 Atomic Technology 400
Decision in Bracco-Jubilant case under review
By AuntMinnie.com staff writers
The U.S. International Trade Commission has agreed to review a ruling by an administrative law judge that Jubilant DraxImage did not violate unfair competition with the exportation of its rubidium elution systems into the U.S., as alleged in a complaint from contrast developer Bracco Diagnostics.
October 2, 2019
2016 12 21 15 58 26 460 Scales Of Justice 400
ITM, Bruce Power complete feasibility study
By AuntMinnie.com staff writers
German radiopharmaceutical group ITM Isotopen Technologien München and Canadian isotope supplier Bruce Power have completed a joint feasibility study for the irradiation of ytterbium-176 to produce lutetium-177.
October 1, 2019
2016 10 18 11 34 57 70 Check Mark 400
Shine, Phoenix claim world record
By AuntMinnie.com staff writers
Medical isotope firm Shine Medical Technologies and nuclear technology company Phoenix are laying claim to a new world record for a nuclear fusion reaction.
October 1, 2019
2016 09 13 17 07 43 134 Atomic Technology 400
CMS gets pushback on PET fee cuts
By AuntMinnie.com staff writers
Imaging organizations opposing the U.S. Centers for Medicare and Medicaid Services' (CMS) proposed payment reductions related to myocardial PET equipment and services have received support from 43 members of Congress.
October 1, 2019
2018 11 06 23 34 9504 Pet Scan Patient 400
Previous Page
Page 50 of 438
Next Page